Postchemotherapy retroperitoneal lymph node dissection for testis cancer

Michael C. Risk, Richard S. Foster

Research output: Contribution to journalReview article

3 Scopus citations


The treatment of patients with metastatic testicular cancer is multimodal. Postchemotherapy retroperitoneal lymph node dissection is a technically demanding procedure that can benefit appropriately selected patients. In this article, we review postchemotherapy retroperitoneal lymph node dissection, including indications, technical updates, and the management and outcomes of patients who undergo surgery. Many aspects continue to evolve, and we review the evidence regarding current controversies in the field.

Original languageEnglish (US)
Pages (from-to)95-106
Number of pages12
JournalExpert Review of Anticancer Therapy
Issue number1
StatePublished - Jan 1 2011



  • nonseminoma
  • retroperitoneal lymph node dissection
  • seminoma
  • testicular cancer

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this